CLINICAL_TRIALS
trial_result
· 2018-12-19
Clinical Trial Update: Month 30 & 42 Extension Studies of CRD-004 Primary Study [Phase 2]
Summary
Extension studies for CRD-004 in herpes zoster completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Phase 2 | Status: COMPLETED | Results posted: 2018-12-19